Sonim Q3 revenue up 42% YoY to $20.5M; net loss narrows to $1.6M

DNA X, Inc.

2023-Q3 EPS reported -$0.52 revenue$45,710,000

Revenue $20.5M (+42% YoY); net loss $1.6M vs $10.9M loss in Q3 2021.
Gross margin improved to 16.2% from 12.4% a year ago.
Shipped $13.9M in new tablet orders, leveraging ODM capabilities.
Closed $17.5M strategic equity transaction at $0.84 per share.
Next-gen XP10 5G rugged smartphone shipping to major carriers in Q4 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DNA X, Inc. reported the third quarter ended September 30, 2022 results: revenue $20.5 million, net income $1.6 million.

Period: the third quarter ended September 30, 2022
Revenue: $20.5 million
Net income: $1.6 million
Result: reported results

Exact text from the filing

● Net revenues increased 42% year-over-year to $20.5 million, from $14.4 million in the third quarter 2021, and 72% sequentially from $12.0 million in the second quarter 2022 ● Net loss declined to $1.6 million, from a net loss of $10.9 million in the third quarter of 2021 and from a net loss of $4.2 million in the second quarter 2022

View on SEC.gov

20 earnings releases filed in the last 30 days. Browse all earnings releases →

DNA X, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-031981

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.